ArticleScientific reports2025
UV-Vis spectroscopy coupled with firefly algorithm-enhanced artificial neural networks for the determination of propranolol, rosuvastatin, and valsartan in ternary mixtures.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Fedorov algorithm-optimized chemometric spectrophotometry for cefepime-tazobactam microanalysis in plasma and pharmaceuticals with integrated MA and NQS sustainability assessment.Scientific reports · 2026Article
- Environmentally sustainable UV spectrophotometric-chemometric approach for simultaneous determination of budesonide, glycopyrrolate, and formoterol.BMC chemistry · 2026Article
- Development and validation of a green/blue UHPLC-MS/MS method for trace pharmaceutical monitoring.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
In the present study, a simple, rapid and cost-effective analytical method was developed for the simultaneous determination of three commonly prescribed cardiovascular drugs: propranolol, rosuvastatin and valsartan. The method employed artificial neural networks (ANN) to model the relation between the UV absorption spectra of the drugs and their concentrations. An experimental design of 25 samples was employed as a calibration set, and a central composite design of 20 samples was used as a validation set. The firefly algorithm (FA) was evaluated as a variable selection procedure to optimize the developed ANN models resulting in simpler models with improved predictive performance as evident by lower relative root mean square error of prediction (RRMSEP) values compared to the full spectrum ANN models. Validation of the developed FA-ANN models demonstrated excellent accuracy, precision and selectivity for the quantification of the target analytes as per international conference on harmonisation (ICH) guidelines. Additionally, the greenness, analytical practicality and sustainability of the developed models were assessed using the analytical greenness (AGREE), blue applicability grade index (BAGI) and the red-green-blue (RGB) tools, confirming their environmentally friendly, practical and sustainable nature. This research shed the light on the potential of ANN coupled with UV fingerprinting for the rapid and simultaneous determination of critical cardiovascular drugs posing a significant impact on pharmaceutical quality control and patient monitoring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.